PLIANT THERAPEUTICS, INC. — Investor Relations & Filings
Filings indexed
403
across all filing types
Latest filing
2026-04-22
Annual Report
Country
US
United States of America
Listing
US
PLRX
Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of fibrosis and related diseases. The company leverages its expertise in integrin biology to create tissue-specific treatments. Its therapeutic approach centers on modulating integrin activity and inhibiting TGF-β1 signaling, which are key molecular drivers of fibrosis. Pliant utilizes its proprietary discovery platform to advance a pipeline of integrin-based product candidates, aiming to provide safer and more effective therapies for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - PLIANT THERAPEUTICS, INC. (0001746473) (Filer) | 2026-04-22 | English | |
| DEF 14A - PLIANT THERAPEUTICS, INC. (0001746473) (Filer) | 2026-04-22 | English | |
| 8-K - PLIANT THERAPEUTICS, INC. (0001746473) (Filer) | 2026-03-03 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G - PLIANT THERAPEUTICS, INC. (0001746473) (Subject) | 2026-02-10 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 35399473 | ARS - PLIANT THERAPEUTICS, INC. (0001746473) (Filer) | 2026-04-22 | English | ||
| 35399470 | DEF 14A - PLIANT THERAPEUTICS, INC. (0001746473) (Filer) | 2026-04-22 | English | ||
| 32897649 | 8-K - PLIANT THERAPEUTICS, INC. (0001746473) (Filer) | 2026-03-03 | English | ||
| 31570768 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31570763 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 18605600 | SCHEDULE 13G - PLIANT THERAPEUTICS, INC. (0001746473) (Subject) | 2026-02-10 | English | ||
| 31570779 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 31570778 | 4 Filing | 2026-01-26 | English | ||
| 31570771 | 4 Filing | 2026-01-26 | English | ||
| 31570765 | 4 Filing | 2026-01-26 | English | ||
| 31570764 | 4 Filing | 2026-01-26 | English | ||
| 31570829 | 4 Filing | 2026-01-22 | English | ||
| 31570776 | 4 Filing | 2026-01-22 | English | ||
| 31570773 | 4 Filing | 2026-01-22 | English | ||
| 31570767 | 4 Filing | 2026-01-22 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
PILA PHARMA AB
Clinical-stage biotech developing an oral TRPV1 antagonist …
|
PILA | SE | Professional, scientific and te… |
|
Pinnacle Food Group Ltd
A provider of vertical and hydroponic farming systems and d…
|
PFAI | US | Professional, scientific and te… |
|
P&K Skin Research Center Co.,Ltd.
A contract research organization for clinical studies of sk…
|
347740 | KR | Professional, scientific and te… |
|
Plantarc Bio Ltd.
Develops gene discovery and RNAi technologies for crop enha…
|
PLNT | IL | Professional, scientific and te… |
|
Polaryx Therapeutics, Inc.
Clinical-stage biotech developing therapies for rare pediat…
|
PLYX | US | Professional, scientific and te… |
|
Poltreg S.A.
A clinical-stage biotech developing T-regulatory cell thera…
|
PTG | PL | Professional, scientific and te… |
|
Poxel
Biopharma developing treatments for metabolic diseases, wit…
|
POXEL | FR | Professional, scientific and te… |
|
PPK GROUP LIMITED
Commercializes innovative nanomaterials and advanced energy…
|
PPK | AU | Professional, scientific and te… |
|
PRECISION BIOSCIENCES INC
Clinical-stage gene editing company developing therapies fo…
|
DTIL | US | Professional, scientific and te… |
|
Predictive Oncology Inc.
Applies AI and a biobank to predict drug response for oncol…
|
POAI | US | Professional, scientific and te… |
PLIANT THERAPEUTICS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34243/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34243 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34243 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34243 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34243}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PLIANT THERAPEUTICS, INC. (id: 34243)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.